Bio-Techne Corporation (NASDAQ:TECH) stock reported trading -3.27% off 52-week high price. On the other end, the stock has been noted 49.35% away from low price over the last 52-weeks. The stock disclosed a move of 0.98% away from 50 day moving average and 5.90% away from 200 day moving average. Moving closer, we can see that shares have been trading -1.06% off 20-day moving average. It has market cap of $8.34B and dividend yield of 0.59%.
On Jan. 7, 2020, Bio-Techne Corporation (NASDAQ:TECH) declared that the Atlanta Biologicals portfolio of serum and media will be rebranded as R&D Systems. As part of the rebranding, the Atlanta Biologicals website will be retired and the entire serum and media portfolio, including product details and purchasing options, will be maintained through the R&D Systems website. Currently all serum and media products can be purchased through R&D Systems.
Dave Eansor, President of Bio-Techne’s Protein Sciences Segment, commented, We are excited to consolidate the Atlanta Biologicals portfolio within R&D Systems’ extended offering of cell culture solutions. By rolling the Atlanta Biologicals brand into R&D Systems, researchers will benefit from ensured product quality, an expanded portfolio of culture regents and an experience that enables the purchase of media, serum, proteins, antibodies, and more from a single, trusted source.
The USA based company Bio-Techne Corporation moved with change of -0.54% to $215.98 with the total traded volume of 107297 shares in Tuesday session versus to an average volume of 122.06K shares. The stock was observed in the 5 days activity at -0.68%. The one month performance of stock was -0.82%. TECH’s shares are at 7.09% for the quarter and driving a 48.05% return over the course of the past year and is now at -1.61% since this point in 2018. Right now the stock beta is 1.24. The average volatility for the week and month was at 1.72% and 1.87% respectively. There are 38.60M shares outstanding and 37.93M shares are floated in market.